The latent membrane protein 1 (LMP1) oncogene of Epstein-Barr virus (EBV) is selectively expressed in the Reed-Sternberg (RS) cells of EBV-associated Hodgkin's disease (HD). However, no dierences in clinical presentation and course are found between EBV positive and EBV negative forms of HD suggesting a common pathogenetic mechanism. We have studied the LMP1 associated signaling pathways and their dominant negative inhibition in the myelomonocytic HD-MyZ and the B-lymphoid L-428 HD cell lines. In both EBV negative cell lines expression of LMP1 is associated with the formation of multinuclear RS cells. Dominant negative inhibition of NF-kB mediated signaling at the step of IkB-a phosphorylation results in increased cell death with only a few typical RS cells resistant to overexpression of the dominant negative inhibitor IkB-a-ND54. However, dominant negative inhibition of NF-kB mediated signaling at the early step of TRAF2 interaction results in the formation of multinuclear cells in both cell lines and, in addition, in clusters of small mononuclear cells in the HD-MyZ cell line. In HD-MyZ cells overexpression of the powerful JBD-inhibitor of the JNK signal transduction pathway is restricted to small cells and never observed in RS cells. These small cells undergo apoptosis as shown by the TUNEL technique. Apoptosis of small cells is still observed after cotransfection of JBD and LMP1 but in addition a few apoptotic HD-MyZ cells with large fused nuclear masses are identi®ed suggesting that speci®c inhibition of JNK leads also to apoptosis of LMP1 induced RS cells. Thus, activation of the JNK signaling pathway is also important in the formation of Reed-Sternberg cells. Our ®ndings are consistent with a model where all three LMP1 associated functions, i.e. NF-kB mediated transcription, TRAF2 dependent signaling, and c-Jun activation act as a common pathogenetic denominator of both EBV negative and EBV positive HD.
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Keywords: LMP1; Reed-Sternberg cells; TRAF2; JNK pathway Latent membrane protein 1 (LMP1), encoded by the BNLF1 gene of Epstein-Barr virus was identi®ed as a viral oncogene because of its capacity to transform rodent ®broblasts in vitro and to render them tumorigenic in nude mice (Wang et al., 1985; Baichwal and Sugden, 1988; Moorthy and Thorley-Lawson, 1993) . In particular, LMP1 is a powerful inducer of NF-kB mediated transcription (HammarskjoÈ ld and Simurada, 1992; Herrero et al., 1995; Huen et al., 1995; Mitchell and Sugden, 1995) and engages signaling proteins of the tumor necrosis factor receptor-associated factor (TRAF) family (Mosialos et al., 1995) . TRAF proteins are a family of recently discovered signal transducers interacting with the cytoplasmic domains of the TNFR family (Rothe et al., 1994) . So far, six members called TRAF1-6 have been described (Regnier et al., 1995; Baker and Reddy, 1996; Cao et al., 1996; Takeuchi et al., 1996) . TRAF2 has been identi®ed as a common mediator of TNFR1, TNFR2, CD30 and CD40 induced NF-kB activation (Rothe et al., 1995a; Liu et al., 1996; Duckett et al., 1997) . TRAF2 mediates about 25% of LMP1 induced NF-kB activation through direct interaction with amino acids 199 ± 231, designated as the c-terminal activation region 1 (CTAR 1) of LMP1 Kaye et al., 1996; Brodeur et al., 1997; Floettmann and Rowe, 1997) . However, most of the LMP1 mediated NF-kB activation is dependent on the integrity of the outermost amino acids at positions 383 ± 386 of CTAR2 (Brodeur et al., 1997; Sandberg et al., 1997) . This part of the LMP1 mediated NF-kB activation is thought to occur through direct binding of TRADD (tumor necrosis factor associated death domain protein) which then interacts with TRAF2, thus mimicking TNFR1 mediated NF-kB activation (Izumi and Kie, 1997) . Moreover, mimicking of CD40 dependent signal transduction by LMP1 (Eliopoulos et al., 1996; Kilger et al., 1998) and CTAR2 dependent activation of the AP-1 family of transcription factors (Whitmarsh and Davis, 1996; Karin et al., 1997) through the c-Jun N-terminal kinase (JNK) pathway have recently been reported (Kieser et al., 1997) . Interestingly, the JNK pathway is also activated upon TRAF2 overexpression (Reinhard et al., 1997) . The ability of LMP1 to act as a ligand-independent, permanently activated receptor , its direct and indirect interactions with TRAF2 to bypass physiological regulatory mechanisms, together with its ability to inhibit apoptosis (Henderson et al., 1991; Martin et al., 1993) may therefore result in sustained proliferation or cell death depending on the activity of intracellular signal transducers.
Hodgkin's disease (HD) is a malignant lymphoproliferative disorder ordinarily originating in lymph nodes and diagnosed by histological identi®cation of typical bi-or multinucleated giant cells, called ReedSternberg (RS) cells (Urba and Longo, 1992; Kadin, 1994) . Immunophenotypic and molecular studies performed on tumor tissue, single RS cells or HD cell lines are consistent with the hypothesis that RS cells are derived from several hematopoietic lineages including the lymphoid, monocytoid, dendritic and granulocytic dierentiation pathway (reviewed by Haluska et al., 1994) . Clonal rearrangements of TcRor J H genes have been identi®ed by the Southern technique in about 15% of 602 HD cases (Drexler, 1994) . In RS cells engaged in the B cell dierentiation pathway, clonal populations may emerge by escaping antigen-driven apoptosis in the germinal center, as recently documented (Kanzler et al., 1996) . However, irrespective of their genotype most primary and cultured RS cells express CD30 and CD40, both belonging to the TNFR family (Stein et al., 1985; DuÈ rkop et al., 1992; Carbone et al., 1995) .
About 40% of all HIV negative HD cases are associated with EBV (reviewed by Glaser et al., 1997) . Immunohistochemical and RT ± PCR studies reveal a high amount of the EBV encoded LMP1 in the RS cells from most of these patients (Herbst et al., 1991; Pallesen et al., 1991; Joske et al., 1992) . Integrity of LMP1 dependent NF-kB mediated transcriptional activation appears to be biologically relevant in EBVassociated HD, because all naturally occurring LMP1 deletion variants (LMP1-del) isolated from such patients (Knecht et al., 1993) still fully stimulate NFkB mediated transcription (Rothenberger et al., 1997) . Constitutive NF-kB activation is also observed in RS cells and HD cell lines and appears to be required for sustained survival of the tumor cells (Bargou et al., 1996 (Bargou et al., , 1997 . Moreover, expression of the multifunctional oncoprotein LMP1 in the EBV negative HD cell line L-428 is associated with an increased number of RS cells (Knecht et al., 1996) consistent with the hypothesis that identical signal transduction pathways are relevant in RS cells of EBV negative and EBV positive HD and that consequently the dominant negative inhibitors of LMP1 associated signaling pathways are also acting in LMP1 negative HD.
In order to determine whether speci®c LMP1 mediated functions were associated with the formation of RS cells we have transfected the EBV negative HD cell lines HD-MyZ (Bargou et al., 1993) and L-428 (Schaadt et al., 1979) with LMP1 and the dominant negative inhibitors IkB-a-ND54, TRAF2-ND97 and JBD of the JNK interacting protein-1 (JIP-1).
LMP1 promotes formation of multinuclear ReedSternberg cells in EBV negative HD cell lines with myelomonocytic and lymphoid features. Here we show the cytologic changes occurring in the adherently growing HD cell line HD-MyZ after Lipofectin based transfection of LMP1. About 20 ± 30% of the cells expressed the oncoprotein after 24 h. At timepoint 48 h over 40% of the LMP1 positive cells showed bi-or multinuclearity or increased cellular volume (at least twice as large as the average mononuclear nonexpressing HD-MyZ cells ( Figure 1a , Table 1 ). Clusters of LMP1 expressing RS cells were still identi®ed after 168 h (Figure 1b) . However, at this timepoint the total number of LMP1 positive cells was less than 30% of the total number identi®ed 48 h post transfection. Decreasing numbers of LMP1 expressing cells were rather due to a loss of oncoprotein expression than to toxicity since no apoptotic cells were observed when analysed by the TUNEL technique. Analogous results were obtained after transfection of the naturally occurring LMP1 deletion variants LMP1-del 10 and LMP1-del 23, which fully maintain NF-kB mediated transcriptional activation (immunohistochemistry and Western blot data not shown). However, when transfecting the empty expression vector, or an EBNA1 or EBNA2 expressing plasmid, no changes in cell size were observed (Figure 1c,d) . Electroporation based transfection of L-428 cells yielded about 20% of LMP1 expressing cells with an increasing number of multinucleated forms up to 96 h (Table 1 ) and con®rmed our previous results obtained with the Lipofectin method, much less ecient (eciency 53%) in this cell line (Knecht et al., 1996) . These ®ndings demonstrate that LMP1 behaves as an inducer of multinuclearity in EBV negative HD cell lines and suggests that LMP1 couples to signaling pathways already active in EBV negative HD cell lines.
Dominant negative inhibition of NF-kB (p50/65) at the level of IkB-a phosphorylation is still consistent with RS cell survival. Considering the high constitutive p50/65 expression identi®ed in tumor derived RS cells and the EBV negative HD cell lines L-428 and HDMyZ (Bargou et al., 1996 (Bargou et al., , 1997 we asked whether overexpression of the dominant negative inhibitor IkBa-ND54 abolished RS cell survival. Strong expresion of the dominant negative inhibitor protein was evident on Western blots and still observed in a few typical RS cells of both HD cell lines up to 72 h after transfection (data not shown). These ®ndings con®rm the xenotransplantation results of Bargou et al. (1997) for the HD-MyZ cell line (in these experiments HD-MyZ cells with permanent IkB-a-ND expression were still able to form slowly growing tumors) and demonstrate analogous signaling in the L-428 cell line. Dominant negative inhibition of TRAF2 mediated NF-kB activation at an early step (prior to IkB-a phosphorylation) favors survival of tumor cells with RS morphology. Expression of TRAF2 mRNA has recently been demonstrated in L-428 cells and RS cells originating from clinical tumor samples (Messineo et al, 1998) . Considering the pivotal function of TRAF2 in TNFR related signaling leading to NF-kB activation (reviewed by Baeuerle, 1998) and its interaction with LMP1, we asked whether expression of a dominant negative inhibitor of TRAF2-mediated NF-kB activation at an early step induced morphologically evident changes in HD-MyZ and L-428 cells. Transfection of both cell lines with pcDNA3HA-TRAF2-ND97 resulted in strong protein expression in about 15% of the total number of cells after 24 h and remained essentially unchanged up to 72 h (Table 1, Figure  2a 22+5  26+8  9+2  12+3  21+4  8+2   22+1  49+14  11+5  14+5  29+5  8+2   17+3  50+10  10+2  13+4  35+7  9+3   15+6  58+9  11+2  7+1  29+8  6+2   6+1  68+13  8+3  4+1  31+6 (Figure 2d ). Since such clusters were undetectable up to 96 h, they apparently represent progeny of a single founder cell. Thus, dominant negative inhibition of the NF-kB activation cascade at an early step (prior to IkB-a phosphorylation) appears bene®cial for the survival of RS cells and selected small mononuclear cells which both already constitutively express high levels of NF-kB protein. This at a ®rst glance paradoxical eect may result from still preserved direct or indirect interactions of TRAF2 dominant negative inhibitor protein with other members of the TNFR related signaling complex (Rothe et al., 1997; van Antwerp et al., 1998; Izumi et al., 1999) and shift the balance towards survival. In this context it might be important that the dominant negative TRAF2-ND97 protein expressed in the tumor cells maintains its ability to interact with TRADD and has no inhibitory eect on LMP1-mediated JNK activation (Kieser et al., 1999) . It also maintains the ability to form heterodimers with cIAP through interaction with the conserved TRAF-N domain (Rothe et al., 1995b) . Our ®ndings suggest that dominant negative inhibition of TRAF2 associated signaling pathways prior to IkBa phosphorylation is bene®cial for RS survival in both cell lines and may confer a growth advantage for some tumor cells regardless of their morphological appearance. Transfection of L-428 cells with plasmid pcDNA3-TRAF2, encoding the full length protein, showed signi®cant TRAF2 expression associated with an increase of positive large mononuclear or multinucleated RS cells after 48 h (transfection rate 9+2%; RS cells 46+9%; based on ®ve independent transfection experiments). At 168 h (transfection rate51%) only a very few TRAF2 overexpressing cells (mainly multinuclear) were identi®able. This decrease was due to loss of plasmid expression since apoptotic giant cells were not identi®able when analysed by the TUNEL technique. Thus, TRAF2 overexpression, probably through JNK and NF-kB activation (Reinhard et al., 1997) (6400) strong protein expression at cytological examination and among the positive cells normally sized elements were frequent.
Expression of dominant negative inhibitors of the JNK signaling pathway is associated with small mononuclear HD-MyZ cells and apoptosis. A recently discovered eector function of LMP1 is the induction of the AP-1 family of transcription factors through activation of the JNK pathway resulting in cellular proliferation (Kieser et al., 1997) . This eect is independent of NF-kB activation, mediated through the oncoprotein's CTAR2, and eciently blocked through dominant negative mutants of MAP kinase kinase 4 (designated as MKK4 or SEK1) (Kieser et al., 1997; Eliopulos et al., 1998) . We have tested the eect of dominant negative expression of MKK4 as well as the expression of JBD (JNK binding domain) of JIP-1 (JNK interacting protein 1), a recently identi®ed speci®c cytoplasmic inhibitor of JNK (Dickens et al., 1997) Figure  3d) . No apoptotic cells were identi®ed in the untransfected HD-MyZ cells, LMP1 transfectants or control vector transfectants. These ®ndings suggest that in the HD-MyZ cell line the JIP-1 expression induces apoptosis by a so far not known mechanism even in LMP1 co-expressing cells on the way from mononuclear cells to multinuclear RS cells. Thus, the JNK pathway appears to be critically involved into the formation of RS cells.
In summary our ®ndings demonstrate that LMP1 (TNFR) related signaling pathways are primordial in EBV negative HD cell lines (Figure 4) . TRAF2 associated signaling appears as a major mediator of molecular interactions in RS cells by connecting the NF-kB and the JNK pathways. Since LMP1 is selectively expressed in EBV positive HD and since dominant negative inhibition of LMP1-mediated functions results in profound changes in EBV negative HD cell lines, it appears that both forms of Hodgkin's disease, viz. EBV negative and positive, are manifestations of the same pathogenetical principle, i.e. a particular form of a TNFR related signaling disorder.
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